Artemether

Name Artemether
CAS#  71963-77-4
MF  C16H26o5
MW  298.37
Purity  98%HPLC
Package  25kg/drum
Storage  In sealed, cool and dry condition
Category  Ingredient
Inquiry

Description

Artemether is a medicine that is used to treat malaria. It is an artemisinin derivative, which is a naturally occurring substance obtained from the herb Artemisia annua. Artemether, like other artemisinin derivatives, is extremely effective in the treatment of malaria, especially in situations of severe and drug-resistant malaria.

Artemether kills the malaria parasite by causing it to produce toxic-free radicals. It is frequently used in conjunction with other antimalarial medications, such as lumefantrine, to increase its efficacy and prevent the emergence of drug-resistant parasite strains.

Here are the main benefits and applications of Artemether:

  1. Effective Against Multi-Drug Resistant Malaria: Artemether is particularly effective against strains of malaria that have developed resistance to other antimalarial drugs, making it a valuable treatment option in areas where drug resistance is a problem.
  2. Rapid Action: It acts quickly to reduce the number of malaria parasites in the blood, which helps to alleviate symptoms and prevents the disease from progressing to a more severe stage.
  3. Combination Therapy: Artemether is often used in combination with other antimalarial drugs, such as lumefantrine, to enhance efficacy and reduce the risk of developing resistance. This combination therapy is known as Artemether-Lumefantrine.
  4. Versatile Forms of Administration: It can be administered orally or by intramuscular injection, making it versatile for different healthcare settings and patient needs.
  5. Reduced Risk of Severe Malaria: By rapidly reducing the parasite load, Artemether helps to prevent the progression of malaria to severe forms, which can be life-threatening.
  6. Safety Profile: While all medications have potential side effects, Artemether is generally well-tolerated, and its safety profile is considered favorable, especially in the context of treating a potentially fatal disease like malaria.
  7. World Health Organization Recommendation: The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs), including Artemether, as first-line treatment for uncomplicated Plasmodium falciparum malaria, which is the most dangerous form of the disease.
  8. Global Impact: Artemether has played a significant role in the global fight against malaria, contributing to the reduction in malaria-related mortality, especially in endemic regions like sub-Saharan Africa.